Your body is unique and has its own healing timeline
Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which occur in approximately 16-44% of patients depending on the product and dose according to clinical trials
Mekonnen BD, Ayalew MZ, Tegegn AA (2021) Rational drug use evaluation based on World Health Organization core drug use indicators in Ethiopia: a systematic review
Lipid profile improvements (TRIUMPH-4): Non-HDL cholesterol: Clinically meaningful reduction Triglycerides: Significant reduction hsCRP (inflammatory marker): Significant reduction HDL cholesterol: Not significantly improved (consistent with Phase 2 findings) The triglyceride reduction is particularly notable and likely related to glucagon receptor activation, which enhances fat oxidation
GLP-1 medications suppress appetite and can reduce overall caloric intake, which may theoretically impact milk production if maternal nutrition becomes inadequate
Compounders claim that these products are tailored medicine for patients
